Finance

Beta
Lists
4569:TYO
Kyorin Pharmaceutical Co Ltd
¥1,154.00
+0.96%
(+11.00) 1D
Jun 26, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4569...
Open
¥1,148
High
¥1,159
Low
¥1,138
Mkt. cap
69.18B
Avg. vol.
271.38K
Volume
150.10K
Dividend
4.94%
Quarterly dividend
¥14
Ex-dividend date
Mar 30, 2026
P/E ratio
19.23
52-wk high
¥1,725
52-wk low
¥1,067
EPS
¥60
Shares outstanding
63.52M
No. of employees
2K
Open
¥1,148
High
¥1,159
Low
¥1,138
Mkt. cap
69.18B
Avg. vol.
271.38K
Volume
150.10K
Dividend
4.94%
Quarterly dividend
¥14
Ex-dividend date
Mar 30, 2026
P/E ratio
19.23
52-wk high
¥1,725
52-wk low
¥1,067
EPS
¥60
Shares outstanding
63.52M
No. of employees
2K
News stories
From sources across the web
About Kyorin Pharmaceutical Co Ltd
CEO-
Employees1.98K
Founded1923
Headquarters-
SectorPharmaceutical industry
Websitekyorin-pharm.co.jp
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
30.23B
28.50B
33.72B
33.80B
Cost of goods sold
16.97B
16.87B
19.09B
21.71B
Cost of revenue
16.97B
16.87B
19.09B
21.71B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.89B
12.64B
11.39B
13.13B
Operating expense
10.89B
12.69B
11.39B
13.13B
Total operating expenses
27.86B
29.56B
30.48B
34.84B
Operating income
2.37B
-1.06B
3.24B
-1.04B
Other non operating income
15.00M
11.00M
12.00M
13.00M
EBT including unusual items
2.73B
-699.00M
3.49B
-1.07B
EBT excluding unusual items
2.62B
-1.04B
3.51B
-1.07B
Income tax expense
628.00M
-93.00M
869.00M
-402.00M
Effective tax rate
23.02%
13.30%
24.87%
37.47%
Other operating expenses
-
-
-
-
Net income
2.10B
-606.00M
2.62B
-671.00M
Net profit margin
6.95%
-2.13%
7.78%
-1.99%
Earnings per share
-
-
-
-
Interest and investment income
233.00M
38.00M
235.00M
12.00M
Interest expense
-64.00M
-61.00M
-59.00M
-70.00M
Net interest expenses
169.00M
-23.00M
176.00M
-58.00M
Depreciation and amortization charges
2.00M
3.00M
3.00M
2.00M
EBITDA
3.52B
82.00M
4.39B
121.75M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of 4569
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer